JPWO2023044424A5 - - Google Patents
Info
- Publication number
- JPWO2023044424A5 JPWO2023044424A5 JP2024516751A JP2024516751A JPWO2023044424A5 JP WO2023044424 A5 JPWO2023044424 A5 JP WO2023044424A5 JP 2024516751 A JP2024516751 A JP 2024516751A JP 2024516751 A JP2024516751 A JP 2024516751A JP WO2023044424 A5 JPWO2023044424 A5 JP WO2023044424A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- vector
- itr2
- itr1
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245666P | 2021-09-17 | 2021-09-17 | |
| US63/245,666 | 2021-09-17 | ||
| US202263331441P | 2022-04-15 | 2022-04-15 | |
| US63/331,441 | 2022-04-15 | ||
| US202263341737P | 2022-05-13 | 2022-05-13 | |
| US63/341,737 | 2022-05-13 | ||
| PCT/US2022/076563 WO2023044424A1 (en) | 2021-09-17 | 2022-09-16 | Frataxin gene therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534415A JP2024534415A (ja) | 2024-09-20 |
| JP2024534415A5 JP2024534415A5 (https=) | 2025-09-24 |
| JPWO2023044424A5 true JPWO2023044424A5 (https=) | 2025-09-24 |
Family
ID=85603625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516751A Pending JP2024534415A (ja) | 2021-09-17 | 2022-09-16 | フラタキシン遺伝子療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240376497A1 (https=) |
| EP (1) | EP4401756A4 (https=) |
| JP (1) | JP2024534415A (https=) |
| KR (1) | KR20240082353A (https=) |
| AU (1) | AU2022345283A1 (https=) |
| CA (1) | CA3231881A1 (https=) |
| CO (1) | CO2024004573A2 (https=) |
| IL (1) | IL311499A (https=) |
| MX (1) | MX2024003241A (https=) |
| TW (1) | TW202321455A (https=) |
| WO (1) | WO2023044424A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110139933B (zh) | 2016-11-09 | 2024-03-08 | 英特瑞克斯顿股份有限公司 | 共济蛋白表达构建体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110139933B (zh) * | 2016-11-09 | 2024-03-08 | 英特瑞克斯顿股份有限公司 | 共济蛋白表达构建体 |
| WO2019076973A1 (en) * | 2017-10-17 | 2019-04-25 | Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol | VECTORS FOR THE TREATMENT OF FRIEDREICH ATAXIA |
| AU2019385506A1 (en) * | 2018-11-21 | 2021-06-03 | Takeda Pharmaceutical Company Limited | Recombinant viral vectors and nucleic acids for producing the same |
| EP4085144A4 (en) * | 2019-12-19 | 2024-03-27 | The Trustees of The University of Pennsylvania | COMPOSITIONS FOR THE TREATMENT OF FRIEDREICH AAXIA |
-
2022
- 2022-09-16 IL IL311499A patent/IL311499A/en unknown
- 2022-09-16 US US18/692,672 patent/US20240376497A1/en active Pending
- 2022-09-16 AU AU2022345283A patent/AU2022345283A1/en active Pending
- 2022-09-16 CA CA3231881A patent/CA3231881A1/en active Pending
- 2022-09-16 JP JP2024516751A patent/JP2024534415A/ja active Pending
- 2022-09-16 EP EP22870975.4A patent/EP4401756A4/en active Pending
- 2022-09-16 WO PCT/US2022/076563 patent/WO2023044424A1/en not_active Ceased
- 2022-09-16 MX MX2024003241A patent/MX2024003241A/es unknown
- 2022-09-16 KR KR1020247012580A patent/KR20240082353A/ko active Pending
- 2022-09-19 TW TW111135360A patent/TW202321455A/zh unknown
-
2024
- 2024-04-11 CO CONC2024/0004573A patent/CO2024004573A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI856016B (zh) | 腺相關病毒載體遞送肌肉特異性微小肌縮蛋白以治療肌肉萎縮症 | |
| US11938197B2 (en) | Polynucleotides and vectors for the expression of transgenes | |
| JP7162021B2 (ja) | 筋ジストロフィーを治療するためのマイクロジストロフィン断片のアデノ随伴ウイルスベクター送達 | |
| JP4769417B2 (ja) | アデノ随伴ウイルス（ａａｖ）血清型９の配列、それを含むベクターおよびその使用 | |
| JP6174318B2 (ja) | アデノ随伴ウイルス構築物を含んでなるコンダクティング気道細胞を標的とするための組成物 | |
| JP2021512649A5 (https=) | ||
| US20090186002A1 (en) | rAAV-delivered alpha-1-antitrypsin compositions and method for the treatment and prevention of diabetes | |
| RU2021102893A (ru) | Модифицированные гены атаксии фридрейха и векторы для генной терапии | |
| US20190070271A1 (en) | Factor ix gene therapy | |
| JPWO2021077000A5 (https=) | ||
| US20250269065A1 (en) | B-cell lymphoma 2-associated anthanogene 3 (bag3) gene therapy using aav vector | |
| JPWO2020106916A5 (https=) | ||
| JPWO2019153009A5 (https=) | ||
| JP7707081B2 (ja) | 網膜細胞を標的とした最適化された遺伝子治療 | |
| JPWO2020069339A5 (https=) | ||
| KR20250061713A (ko) | 유전자의 망막 세포 내 발현을 위한 프로모터 및 이를 포함하는 벡터 시스템 | |
| JPWO2023044424A5 (https=) | ||
| RU2024110159A (ru) | Генная терапия фратаксином | |
| WO2023022634A1 (ru) | Выделенный модифицированный белок vp1 капсида aav9 | |
| JPWO2021221995A5 (https=) | ||
| JPWO2022028472A5 (https=) | ||
| WO2025162449A1 (en) | Compositions and methods for the treatment of heart disease | |
| RU2825667C2 (ru) | Выделенный модифицированный белок VPI капсида аденоассоциированного вируса 9 серотипа (AAV9), капсид и вектор на его основе | |
| US20240254181A1 (en) | Recombinant adeno-associated virus products and methods for treating dystroglycanopathies and laminin-deficient muscular dystrophies | |
| WO2025023319A1 (ja) | 脳指向性ａａｖ変異体 |